Market Research Report Store Kyowa Hakko Kirin Co Ltd (4151) - Pharmaceuticals | Seite 4

Kyowa Hakko Kirin Co Ltd, Medical Devices Deals, 2011 to YTD 2017
12
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
16
16
ProStrakan Acquires Breast Cancer Product Fareston From GTx For US$22 Million
ProStrakan Acquires Abstral From Orexo For US$85 Million
Partnerships
13
16
17
18
Kyowa Hakko Kirin Enters into Agreement with AstraZeneca
Medgenics Enters into Agreement with Kyowa Hakko Kirin
18
19
Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter
into Agreemet with Four Research Institutions
20
AstraZeneca Enters into Option Agreement with Kyowa Hakko Kirin
Japan Blood Products Enters into Agreement with Kyowa Hakko Kirin
22
22
Leo Pharma Enters into Distribution and Co-Promotion Agreement with Kyowa Hakko Kirin
NovAliX Enters Into Agreement With Kyowa Hakko Kirin To Develop Drug Candidates
Activiomics Extends Research Agreement With Kyowa Hakko Kirin
23
24
25
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery
NovAlix Enters Into Drug Discovery Agreement With Kyowa Hakko Kirin
27
Adimab Enters Into Antibody Discovery Agreement With Kyowa Hakko Kirin
27
Genmab Enters Into Agreement With Kyowa Hakko Kirin For Bispecific Antibodies
Activiomics Enters Into Research Agreement With Kyowa Hakko
28
29
Anchor Therapeutics Enters Into Research Agreement With Kyowa Hakko Kirin
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin
25
30
31
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate
32